NCT02502942

Brief Summary

Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent collapse of the upper airway during sleep. OSA patients have a small upper airway that is kept patent during wakefulness by a compensatory increase in upper airway (UA) dilator muscle (e.g. genioglossus) activity. At sleep onset this compensation is reduced or lost, resulting in upper airway narrowing or collapse. Previous studies of upper airway muscle training showed variable results on OSA, but so far there has not been any practical, long-term, systematic upper airway muscle training developed or studied as the treatment of OSA. In theory, strengthening the upper airway muscle with exercise training in theory helps maintain a patent airway during sleep. Therefore, investigators aim to test the hypothesis: 1) UA muscle training can improve sleep apnea in some patients with OSA, including those already receiving treatment with PAP or oral appliance therapy. 2) Muscle training is a viable therapy for a definable subset of OSA patients. Investigators hypothesize that patients with OSA who have mild or moderately compromised upper airway anatomy will benefit the most. 3)There will be a positive association between the changes in muscle function and improvement in OSA severity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
134

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 20, 2015

Completed
12 days until next milestone

Study Start

First participant enrolled

August 1, 2015

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 24, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2019

Completed
Last Updated

November 27, 2019

Status Verified

November 1, 2019

Enrollment Period

3.9 years

First QC Date

July 12, 2015

Last Update Submit

November 25, 2019

Conditions

Keywords

Obstructive Sleep ApneaExerciseUpper airway muscle

Outcome Measures

Primary Outcomes (2)

  • Change of severity of obstructive sleep apnea, measured as apnea hypopnea index (AHI), for untreated OSA group and oral appliance group

    Home sleep test is used to measure AHI.

    Baseline and after 6-week exercise training

  • Change of severity of obstructive sleep apnea, measured as 95th percentile pressures, for PAP therapy group

    95th percentile pressures (2 week period) of autotitrating CPAP will be used to assess the effects of upper airway muscle exercise on muscle strength.

    Baseline and after 6-week exercise training

Secondary Outcomes (6)

  • Change of sleepiness measured by Epworth Sleepiness Scale (ESS)

    Baseline and after 6-week exercise training

  • Change of sleep quality measured by Pittsburgh Sleep Quality Index (PSQI)

    Baseline and after 6-week exercise training

  • Change of subjective quality of life measured by SF-36

    Baseline and after 6-week exercise training

  • Change of neurocognitive function measured by psychomotor vigilance test (PVT)

    Baseline and after 6-week exercise training

  • Change of upper airway anatomy evaluated with acoustic pharyngometry

    Baseline and after 6-week exercise training

  • +1 more secondary outcomes

Study Arms (4)

Untreated OSA Muscle Exercise Group

EXPERIMENTAL

Patients who were previously diagnosed of obstructive sleep apnea (OSA) with apnea hypopnea index (AHI) \> 10 events/hr and have previously failed or refused PAP therapy. In this group, patients will learn and practice upper airway muscle exercise for six weeks.

Behavioral: Upper Airway Muscle Exercise

PAP Therapy Muscle Exercise Group

EXPERIMENTAL

OSA patients who are currently treated with PAP for their OSA (with AHI of previous sleep study \> 10 events/hr). In this group, patients will learn and practice upper airway muscle exercise for six weeks.

Behavioral: Upper Airway Muscle Exercise

Oral Appliance Muscle Exercise Group

EXPERIMENTAL

OSA patients who are currently treated with an oral appliance with residual AHI \> 10 events/hr. In this group, patients will learn and practice upper airway muscle exercise for six weeks.

Behavioral: Upper Airway Muscle Exercise

Normal Control Sham Exercise Group

ACTIVE COMPARATOR

Patients of untreated OSA group, PAP therapy group, and oral appliance group are randomized to upper airway muscle exercise versus sham exercise.

Behavioral: Sham Exercise

Interventions

Patients will use an individualized oral retainer device for upper airway muscle training exercises daily for 20 minutes each day (10 minutes in the morning and 10 minutes in the afternoon/evening) for 6 weeks.

Oral Appliance Muscle Exercise GroupPAP Therapy Muscle Exercise GroupUntreated OSA Muscle Exercise Group
Sham ExerciseBEHAVIORAL

Patients will be given an individualized oral retainer device and instructed to do deep breathing exercise twice daily for 6 weeks.

Normal Control Sham Exercise Group

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Prior diagnosis of OSA with AHI\>10 events/hr.
  • PAP group: subjects who have been on PAP treatment for at least 3 month, with good compliance (at least 4 hours a day and use PAP for \>70% of the time).
  • Untreated group: untreated subjects with generally mild OSA as defined by AHI\<20 events/hr and nadir SaO2\>70%. Additionally, investigators will also recruit OSA subjects of all severities who have previously tried but are not currently using PAP.
  • Oral appliance treatment group: subjects have residual AHI \>10 events/hr with oral appliance therapy.

You may not qualify if:

  • In those with untreated sleep apnea, severe sleepiness with current Epworth Sleepiness Scale (ESS) \> 18 or history of motor vehicle accident due to obstructive sleep apnea
  • Taking medications classified as a muscle relaxant
  • Pregnant women.
  • Psychiatric disorder, other than mild and controlled depression; e.g. schizophrenia, bipolar disorder, major depression, panic or anxiety disorders.
  • Current smokers, alcohol (\>3oz/day) or use of illicit drugs.
  • More than 10 cups of beverages with caffeine (coffee, tea, soda/pop) per day.
  • Unstable cardiac disease (e.g. congestive heart failure)
  • Pulmonary disease (apart from well controlled mild asthma and OSA)
  • Systemic neuromuscular disease
  • Other systemic disease that affects breathing (e.g. stroke) or those with expected survival \< 1 year.
  • Poor oral condition, including: active periodontal disease, loose or broken teeth, lack of eight teeth in each arch, active TMJ dysfunction
  • Known allergy to oral appliance components

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Diego

San Diego, California, 92093, United States

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesBehavior

Study Officials

  • Atul Malhotra, MD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 12, 2015

First Posted

July 20, 2015

Study Start

August 1, 2015

Primary Completion

June 24, 2019

Study Completion

June 24, 2019

Last Updated

November 27, 2019

Record last verified: 2019-11

Locations